Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients.

Breast Cancer (Auckl) · 2016 · PMC4760670 · PMID 26917965

Europe PMC DOI

hedged sentence

0.1180

closest p · 2.4× alpha

0.1180

boldest claim

The sentences

did not reach statistical significanceP = 0.118not close (p > 0.1)

16.5 months), this difference did not reach statistical significance (log rank P = 0.118).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.